Viewing nowCombinationNPIANGDUO Tablet 12.5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.

MFDS item code 202302664 · Approved 2023.09.06 · Insurance code 669908460
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to assist in blood sugar control in adult patients with type 2 diabetes who are using empagliflozin and metformin together, in conjunction with diet and exercise. It may be administered especially in cases of adult patients with cardiovascular disease where blood sugar control is insufficient. However, it is important to refer to specialized precautionary guidelines regarding the risk of cardiovascular events. This medication is effective for blood sugar management and aids in safe treatment.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is needed in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with empagliflozin and metformin as separate single-ingredient products. The maximum daily dose of metformin hydrochloride that may be given with this medicine is 1000 mg, administered as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Cautious Administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication is a diabetes treatment that helps control blood sugar. It can cause a rare but severe side effect known as lactic acidosis, so it should not be administered to patients with poor kidney function or severe infections, dehydration, or heart problems. Additionally, when used together with insulin or other blood sugar-lowering medications, hypoglycemia symptoms may occur, so caution is needed. This medication can be affected by kidney function, requiring regular kidney function tests before and during treatment. Particularly, in patients with severely reduced kidney function or those with acute illness or undergoing surgery, it should be avoided or temporarily discontinued. This medication may increase the risk of urinary tract infections and genital infections, so if any infection symptoms occur, consult healthcare professionals immediately. During treatment, gastrointestinal disturbances such as nausea, vomiting, diarrhea, abdominal pain may occur, and hypoglycemia symptoms should also be monitored. It is safer for pregnant or breastfeeding women to avoid using this medication. Alcohol intake may increase the risk of side effects from this medication, thus it should be avoided. Elderly patients or those with poor nutritional status also require special caution when taking this medication. Patients taking this medication should have regular blood tests and kidney function tests, and any unusual symptoms should be discussed with a doctor immediately. Finally, patients taking this medication should store it out of reach of children and keep it in its original container.
Hypoglycemia, urinary tract infection, genital infection, increased urination, reduction and deficiency of vitamin B12, ketoacidosis, lactic acidosis, decreased fluid volume, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, dysgeusia, pruritus, rash, urticaria, erythema, angioedema, dysuria, interstitial nephritis, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, increased hematocrit, perineal necrosis, vulvovaginal candidiasis, vulvitis, balanitis, fluid loss, increased serum creatinine, decreased glomerular filtration rate, gastrointestinal symptoms (diarrhea, nausea, vomiting), chronic gastritis, various neurological disorders, cerebral infarction, soft tissue infection, pneumonia, ankle fracture, lateral epicondylitis, facial bone fracture, musculoskeletal pain, myocardial infarction, urosepsis, pyelonephritis, rash, urticaria, angioedema, perineal necrosis, constipation, gastritis, abdominal discomfort, anal incontinence, dry mouth, gastrointestinal disorders, gastroesophageal reflux disease, oral discomfort, salivary gland pain, headache, sensory loss, postural dizziness, dizziness, weakness, chest discomfort, chest pain, weight loss, vulvar pruritus, benign prostatic hyperplasia, diabetic retinopathy, diplopia, hypertension, insomnia, anxiety, acute cholecystitis, autoimmune hepatitis, cholelithiasis, otalgia, positional vertigo, vertigo, anemia, lymphadenopathy, hypothyroidism, thyroid nodules, diabetic foot, dermoid cyst, seborrheic dermatitis, atopic dermatitis, nummular eczema, heat rash, sebaceous gland hyperplasia, lumbar spinal canal stenosis, myalgia, limb pain, musculoskeletal chest pain, arthralgia, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscular weakness, osteoarthritis, osteoporosis, rotator cuff syndrome, astigmatism, cataract, allergic conjunctivitis, blurred vision, corneal abrasion, glaucoma, macular fibrosis, ocular discomfort, eye congestion, pathological myopia, retinal detachment, retinal crystals, retinal vein occlusion, tear retinal detachment, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, nasal bleeding, asthma, exercise-induced dyspnea, wet cough, allergic rhinitis, residual sputum, skin laceration, bruise, rib fracture, concussion, corneal abrasion, fall, hand fracture, iliotibial band syndrome, open globe injury, pelvic fracture, road traffic accident, splenic injury, sternum fracture, angina, palpitations, Prinzmetal angina, coronary artery disease, tachycardia, atherosclerosis, deep vein thrombosis, diabetic vascular disorders, peripheral arterial occlusive disease, unstable angina, anxiety, depression, sleep disorders
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. Additionally, avoid direct sunlight and store at room temperature between 1 to 30 degrees Celsius.
A biconvex oval film-coated tablet with a dark brownish-purple color.
10 tablets/box [(10 tablets/PTP × 1)], 60 tablets/box [(10 tablets/PTP × 6)], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.